A detailed history of Windsor Advisory Group, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Windsor Advisory Group, LLC holds 416,757 shares of APLT stock, worth $220,881. This represents 0.41% of its overall portfolio holdings.

Number of Shares
416,757
Previous 198,987 109.44%
Holding current value
$220,881
Previous $1.69 Billion 78.9%
% of portfolio
0.41%
Previous 1.91%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.82 - $10.24 $178,571 - $2.23 Million
217,770 Added 109.44%
416,757 $357 Million
Q3 2024

Nov 14, 2024

BUY
$4.35 - $8.5 $865,593 - $1.69 Million
198,987 New
198,987 $1.69 Billion

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $25.5M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Windsor Advisory Group, LLC Portfolio

Follow Windsor Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Windsor Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Windsor Advisory Group, LLC with notifications on news.